LP

Leo Paul Erinjery Johnson

Active Director Director DIN 11264205
DIN 11264205 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Leo Paul Erinjery Johnson

Data last updated:

Leo Paul Erinjery Johnson is a Director at Syncinvent Labs Private Limited (since 2025).

DIN 11264205
Primary Designation Director
First Appointment 27 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Syncinvent Labs Private Limited U62013KA2025PTC207279
Director27 Aug 20252025Active

Board colleagues of Leo Paul Erinjery Johnson

NameDINCompanyDesignation
Deepak Thomas09115656Syncinvent Labs Private LimitedAdditional Director
Renooj Jacob Chemmannore05251037Syncinvent Labs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Syncinvent Labs Private Limited
Premium access

Shareholding and investment profile for Leo Paul Erinjery Johnson

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Leo Paul Erinjery Johnson

Leo Paul Erinjery Johnson currently holds 1 directorship: Syncinvent Labs Private Limited (Director, since 27 Aug 2025).

Leo Paul Erinjery Johnson was first appointed on 27 Aug 2025 as Director at Syncinvent Labs Private Limited.

The current boards of Leo Paul Erinjery Johnson's companies include Deepak Thomas (Syncinvent Labs Private Limited), Renooj Jacob Chemmannore (Syncinvent Labs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available